Terms: = Kidney tumors AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
5 results:
1. SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.
Liu XD; Zhang YT; McGrail DJ; Zhang X; Lam T; Hoang A; Hasanov E; Manyam G; Peterson CB; Zhu H; Kumar SV; Akbani R; Pilie PG; Tannir NM; Peng G; Jonasch E
Clin Cancer Res; 2023 Oct; 29(19):4002-4015. PubMed ID: 37527013
[TBL] [Abstract] [Full Text] [Related]
2. Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.
Lamers CH; van Elzakker P; van Steenbergen SC; Sleijfer S; Debets R; Gratama JW
Cytotherapy; 2008; 10(4):406-16. PubMed ID: 18574773
[TBL] [Abstract] [Full Text] [Related]
3. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: gmp-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
[TBL] [Abstract] [Full Text] [Related]
4. Induction of apoptosis in renal cell carcinoma by reactive oxygen species: involvement of extracellular signal-regulated kinase 1/2, p38delta/gamma, cyclooxygenase-2 down-regulation, and translocation of apoptosis-inducing factor.
Ambrose M; Ryan A; O'Sullivan GC; Dunne C; Barry OP
Mol Pharmacol; 2006 Jun; 69(6):1879-90. PubMed ID: 16543392
[TBL] [Abstract] [Full Text] [Related]
5. 3',5'-Cyclic diguanylic acid (c-di-gmp) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.
Karaolis DK; Cheng K; Lipsky M; Elnabawi A; Catalano J; Hyodo M; Hayakawa Y; Raufman JP
Biochem Biophys Res Commun; 2005 Apr; 329(1):40-5. PubMed ID: 15721270
[TBL] [Abstract] [Full Text] [Related]
